Many private payers have shared announcements regarding coverage of testing and treatment for COVID-19.  Some policies include:

  • Waiving co-pays for COVID-19 testing
  • Expanding scope of contracted lab partners to support access to testing
  • Confirming that prior authorization and/or referrals will not be required for covered services that are medically necessary and consistent with CDC guidance for beneficiaries diagnosed with COVID-19.
  • Waiving cost-sharing for telemedicine visits for a limited time
  • Waiving prescription refill limits for a limited time

Information regarding updates for several private payers can be accessed below, as it has been made publicly available.

Members are encouraged to check for COVID-19 resources on private payer websites through provider portals and to contact private payers directly for guidance, if requirements for reimbursement for testing and treatment of COVID-19 remain unclear.  Additional reimbursement questions may be sent to